Efficacy and safety of low dose oral prednisolone as compared to pulse intravenous methylprednisolone in managing moderate severe Graves’ orbitopathy: A randomized controlled trial

BACKGROUND: High dose oral prednisolone (100 mg/day) in Graves’ orbitopathy (GO) is limited by lesser response, and greater side-effects compared to intravenous (iv) methylprednisolone. Low dose oral prednisolone has not been evaluated in GO. This study aimed to evaluate the safety and efficacy of l...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Indian J Endocrinol Metab
Main Authors: Roy, Ajitesh, Dutta, Deep, Ghosh, Sujoy, Mukhopadhyay, Pradip, Mukhopadhyay, Satinath, Chowdhury, Subhankar
Formato: Artigo
Idioma:Inglês
Publicado: Medknow Publications & Media Pvt Ltd 2015
Assuntos:
Original Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4366772/
https://ncbi.nlm.nih.gov/pubmed/25932389
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/2230-8210.152770
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares